🎈 Up Big Today: Find today's biggest gainers with our free screenerTry Stock Screener

Auburn National Bancorporation stock hits 52-week high at $22.43

Published 09/25/2024, 10:00 AM
AUBN
-

Auburn National Bancorporation (AUBN) stock reached a 52-week high, touching $22.43 in recent trading. This peak comes amidst a challenging year for the financial sector, with AUBN experiencing a slight 1-year change decline of 0.46%. The achievement of this price level reflects a notable moment for the company, as investors and analysts assess the resilience and potential growth of Auburn National Bancorporation in a fluctuating economic environment.

InvestingPro Insights


Auburn National Bancorporation (AUBN) has not only hit a 52-week high recently, but it also presents some noteworthy financial metrics and trends that investors may consider. According to InvestingPro data, AUBN has a market capitalization of $75.25 million and is trading at a high earnings multiple with a P/E ratio of 124.43, which suggests that investors have high expectations for future earnings growth despite the company's recent revenue decline of 34.81% over the last twelve months as of Q2 2024.

InvestingPro Tips highlight that AUBN has raised its dividend for 22 consecutive years and has maintained dividend payments for 30 consecutive years, with a current dividend yield of 4.98%. This consistent dividend payment track record could be appealing to income-focused investors. Additionally, the stock has seen a significant return over the last week, month, and three months, with price total returns of 9.32%, 16.92%, and 24.75%, respectively.

Investors may also take interest in the fact that AUBN is trading near its 52-week high, at 97.53% of this threshold, which might indicate strong market confidence or, alternatively, a potential reevaluation of its current price levels. For those looking to delve deeper into AUBN's performance and potential, there are more InvestingPro Tips available, which provide a comprehensive analysis of the company's financial health and prospects.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.